← Back to Clinical Trials
Recruiting NCT07759115

NCT07759115 Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07759115
Status Recruiting
Phase —
Sponsor University of Texas at Austin
Condition Multiple Sclerosis
Study Type INTERVENTIONAL
Enrollment 64 participants
Start Date 2026-08-10
Primary Completion 2028-03

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
Music Training InterventionMusic Listening

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 64 participants in total. It began in 2026-08-10 with a primary completion date of 2028-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Multiple sclerosis (MS) rates in the U.S. have nearly doubled over the past decade, making it a leading cause of nontraumatic functional impairment in young adults and significantly affecting cognitive function in up to 70% of people with MS. While traditional cognitive rehabilitation methods are limited in sensory engagement, music training offers a multisensory approach that enhances neuroplasticity and improves cognitive functions. This study investigates the feasibility of Music-4-MS, a 12-week music-based eHealth intervention, to support cognitive and emotional health in individuals with MS.

Eligibility Criteria

Inclusion Criteria: * Diagnosed with multiple sclerosis (relapsing remitting, secondary progressive, primary progressive) * Diagnosed more than 6 months prior to starting study * Self-reported cognitive impairment as assessed by having at leased 5 problems "sometimes" or more often on the Perceived Deficits Questionnaire * Read, write, and understand English * Access to internet Exclusion Criteria: * Diagnosed with another neurological condition that causes cognitive impairment * MS exacerbation within the last 30 days * Professional musician (primary source of income)

Contact & Investigator

Central Contact

Carolyn Phillips, PhD, RN

✉ carolyn.phillips@nursing.utexas.edu

📞 512-475-7039

Principal Investigator

Carolyn Phillips, PhD

PRINCIPAL INVESTIGATOR

University of Texas at Austin

Frequently Asked Questions

Who can join the NCT07759115 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Multiple Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07759115 currently recruiting?

Yes, NCT07759115 is actively recruiting participants. Contact the research team at carolyn.phillips@nursing.utexas.edu for enrollment information.

Where is the NCT07759115 trial being conducted?

This trial is being conducted at Austin, United States.

Who is sponsoring the NCT07759115 clinical trial?

NCT07759115 is sponsored by University of Texas at Austin. The principal investigator is Carolyn Phillips, PhD at University of Texas at Austin. The trial plans to enroll 64 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology